m6A-seq analysis suggests that the constitutively active KRAS mutant overexpression led to an m6A increase in the genes associated with NER, suggesting an important role of the NER pathway in KRAS-mutant–mediated platinum resistance in lung cancer cells. The gene discussed is KRAS; the disease is lung carcinoma.